The Ii antigen system is a human blood group system based upon a gene on chromosome 6 and consisting of the I antigen and the i antigen.[1] The I antigen is normally present on the cell membrane of red blood cells in all adults, while the i antigen is present in fetuses and newborns.[2]
Adult red blood cells express I antigen abundantly.[3] Developing fetuses and newborns express i antigen until around 13-20 months after birth, when I antigen starts to be expressed instead.[3] Like ABH antigens, which make up the ABO blood group, I and i antigens are not restricted to the red blood cell membrane, but are found on most human cells and in body fluids such as saliva.[1]
The I and i antigens are carbohydrate structures composed of repeating units of N-acetyllactosamine (LacNAc), and are located on the interior of structures carrying ABH and Lewis antigens.[1][3] LacNAc repeats are made by the enzymes B3GNT1 and B4GALT1.[4] The i antigen is made of linear repeats, while the structure of the I antigen is branched.[3] Unlike most other blood groups, the two antigens are not encoded by different alleles; rather, I-branching enzyme converts i antigen to I antigen by adding branches.[5][6] The gene encoding I-branching enzyme is located on chromosome 6.[6]
The function of I and i antigens are unknown but may be related to hematopoiesis, the production of blood.[6] The rapid conversion from i to I antigens after birth suggests that I antigen plays an important role in adult red blood cells.[3] The presence of the linear i antigen in fetuses, rather than the branched I antigen, may have developed as an evolutionary mechanism to prevent ABO hemolytic disease of the fetus and newborn.[1] Enhanced expression of i antigen is associated with conditions involving stress hematopoiesis such as leukemia and sickle cell disease.[7]
Transient autoantibodies against I antigen are common, especially after infection by Mycoplasma pneumoniae, and are rarely significant except in cold agglutinin disease.[1] Transient antibodies against i antigen are common after infectious mononucleosis and are also not clinically significant.[1] Antibodies which recognize both I and i antigens are termed anti-j antibodies.[1]
|
Main article: Cold agglutinin disease |
The autoantibodies involved in cold agglutinin disease are usually against I antigen.[8] The antibodies are usually IgM (kappa subtype), unlike transient autoantibodies which are generally IgG.[1] Cold-reactive IgM antibodies (cold agglutinins) bind to I antigen on red blood cells, and unlike IgG, are able to cause agglutination of red blood cells and activate complement to cause hemolysis, leading to anemia.[1][8]
Rarely, individuals have the i antigen on their red blood cells into adulthood, known as the adult i phenotype.[1] This is due to the presence of a mutation in the GCNT2 gene which encodes the I-branching enzyme.[1][3] These individuals have alloantibodies against the I antigen, though these are typically cold agglutinins and are unlikely to cause transfusion reactions.[2][9]
The adult i phenotype is associated with congenital cataracts, most markedly in Japanese and Taiwanese people and least markedly in Caucasian people.[1][6] Cataracts occur when i antigen rather than I antigen is present on the epithelium of the lens, due to a mutation in the form of the I-branching enzyme which is expressed in lens epithelium, IGNTB.[10]
The adult i phenotype is inherited in a recessive manner.[1]
The I antigen was first described in 1956 and the i antigen was discovered in 1960.[1] I and i were the first discovered antigens which change significantly during human development.[4] The letter I was chosen to reflect the "individuality" of a person studied who lacked the I antigen.[6]
A similar blood group system with a developmental change resembling the Ii system (with human neonatal cells expressing i antigen and adult cells expressing I antigen) has been observed in most primates, including chimpanzees and monkeys.[1] This is not seen in non-primates: cats, dogs, or guinea pigs.[1]